In addition, voriconazole, although not a CYP enzyme, has shown non-competitive inhibition of human carbonic anhydrase 1 in its interaction with acetazolamide, and non-competitive inhibition of α-glycosidase in its interaction with acarbose, a drug used for reducing postprandial glucose in type 2 diabetes mellitus [43]. Here, PPIG is linked to type 2 diabetes mellitus.